Latest news
GenePOC announces setup of an extensive network of commercial partners across Europe for Distribution
Debiopharm International SA Reaches Important Development Milestones for its Staphylococcus-selective antibiotic Debio 1450
Debiopharm International SA Announces Clinical Collaboration with the Merck-Pfizer Alliance in Cancer Immunotherapy
Coorpacademy raises 10 million euros and achieves one of the most important fundraisings in the European EdTech sector
The Japanese Cancer Association and Debiopharm Group Announce Winners of the 2016 JCA-Mauvernay Award
Debiopharm invests double digit millions in the Canadian startup GenePOC, specialized in the development of rapid diagnostic tests
Debiopharm International SA initiates clinical phase II study evaluating Debio 1143 in Ovarian Cancer
Stay informed
Don't miss any latest news and announcements on Debiopharm Investment, subscribe to our newsletter.